Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.085 USD | +1.50% | +3.06% | +8.92% |
Mar. 22 | North American Morning Briefing : Stocks Struggle After New Records | DJ |
Mar. 20 | Avid Bioservices Receives Nasdaq Noncompliance Notice | MT |
Financials (USD)
Sales 2024 * | 139M | Sales 2025 * | 166M | Capitalization | 441M |
---|---|---|---|---|---|
Net income 2024 * | -16M | Net income 2025 * | -4M | EV / Sales 2024 * | 3.18 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.67 x |
P/E ratio 2024 * |
-26.3
x | P/E ratio 2025 * |
-112
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.95% |
Latest transcript on Avid Bioservices, Inc.
1 day | +2.80% | ||
1 week | -1.83% | ||
Current month | -9.11% | ||
1 month | -14.36% | ||
3 months | +3.41% | ||
6 months | -31.57% | ||
Current year | +7.38% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Green
CEO | Chief Executive Officer | 60 | 20-07-29 |
Daniel Hart
DFI | Director of Finance/CFO | 50 | 18-07-31 |
Nick Ferguson
CTO | Chief Tech/Sci/R&D Officer | - | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Sargen
BRD | Director/Board Member | 59 | 17-11-26 |
Joseph Carleone
CHM | Chairman | 78 | 17-11-26 |
Catherine Mackey
BRD | Director/Board Member | 68 | 19-07-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 7.08 | +1.43% | 97 536 |
24-03-27 | 6.98 | +2.80% | 712,328 |
24-03-26 | 6.79 | -0.59% | 1,055,104 |
24-03-25 | 6.83 | +1.49% | 710,546 |
24-03-22 | 6.73 | -2.04% | 778,600 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.38% | 441M | |
+0.44% | 90.27B | |
+10.00% | 44.05B | |
-16.40% | 31.45B | |
+44.30% | 23.35B | |
-8.10% | 16.72B | |
-25.64% | 15.09B | |
-9.03% | 12.82B | |
-9.37% | 11.95B | |
+98.58% | 7.67B |